{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T16:32:36Z","timestamp":1754152356184,"version":"3.41.2"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"29","license":[{"start":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T00:00:00Z","timestamp":1752796800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,7,18]]},"abstract":"<jats:p>Employing multivariate statistical methods, we aimed to construct and validate predictive models for distant metastasis (DM) risk and overall survival (OS) in patients with gallbladder cancer (GBC), using data from the surveillance, epidemiology, and end results database maintained by the National Cancer Institute. These models were visualized through the development of intuitive nomograms. We extracted clinical data of all patients diagnosed with GBC between 2010 and 2015 from the surveillance, epidemiology, and end results database. Both univariate and multivariate logistic regression analyses were conducted utilizing R software (Version 4.2.1) to identify independent risk predictors for DM in GBC patients, and univariate and multivariate Cox regression analyses were performed to determine independent prognostic factors for OS among GBC patients with DM. The discriminatory capabilities and predictive accuracies of the developed nomograms were examined through calibration curves, receiver operating characteristic curves, and decision curve analysis. In our study, 3071 patients with GBC were included, of which 759 (24.72%) had DM. Race, T stage, N stage, and tumor size were identified as independent risk factors for DM, while age, surgical intervention, and chemotherapy were independent prognostic factors for OS in GBC patients with DM. The area under the curve for the prognostic nomogram reached 0.726 and 0.730 in the training and validation sets, respectively. The area under the curve for the same nomogram at 6, 9, and 12 months was 0.744, 0.740, and 0.704 for the training set, and 0.798, 0.774, and 0.776 for the validation set, respectively. The calibration curves, decision curve analysis, and Kaplan\u2013Meier survival curves further demonstrated the effectiveness of the nomograms in predicting DM occurrence and the prognosis of GBC patients with DM. Race, T stage, N stage, and tumor size emerged as independent risk factors for DM in GBC patients; whereas age, surgical treatment, and chemotherapy were found to be independent prognostic factors for OS in GBC patients with DM. We successfully established and validated a predictive nomogram for DM occurrence and a prognostic nomogram for OS in GBC patients with DM, both showing high accuracy and clinical utility.<\/jats:p>","DOI":"10.1097\/md.0000000000043369","type":"journal-article","created":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T04:02:40Z","timestamp":1753156960000},"page":"e43369","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Predictive and prognostic models and visualizations of distant metastasis in gallbladder cancer"],"prefix":"10.1097","volume":"104","author":[{"given":"Zhengping","family":"Xiao","sequence":"first","affiliation":[{"name":"Department of Colorectal Hernia Surgery, Binzhou Medical University Hospital, Binzhou, Shandong Province, China"},{"name":"Binzhou Medical University, Binzhou, Shandong Province, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guole","family":"Nie","sequence":"additional","affiliation":[{"name":"Department of Colorectal Hernia Surgery, Binzhou Medical University Hospital, Binzhou, Shandong Province, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xi","family":"Xiao","sequence":"additional","affiliation":[{"name":"Binzhou Medical University, Binzhou, Shandong Province, China"},{"name":"Department of General Medicine, Binzhou Medical University Hospital, Binzhou, Shandong Province, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baosong","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Colorectal Hernia Surgery, Binzhou Medical University Hospital, Binzhou, Shandong Province, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9022-5558","authenticated-orcid":false,"given":"Hong","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Colorectal Hernia Surgery, Binzhou Medical University Hospital, Binzhou, Shandong Province, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250722","doi-asserted-by":"crossref","first-page":"31","DOI":"10.21037\/cco.2019.08.13","article-title":"Gallbladder cancer: epidemiology and genetic risk associations.","volume":"8","author":"Schmidt","year":"2019","journal-title":"Chin Clin Oncol"},{"key":"R2-20250722","doi-asserted-by":"crossref","first-page":"3122","DOI":"10.1186\/s12889-024-20584-9","article-title":"Gallbladder cancer incidence and mortality rate trends in China: analysis of data from the population-based cancer registry.","volume":"24","author":"Zhang","year":"2024","journal-title":"BMC Public Health"},{"key":"R3-20250722","doi-asserted-by":"crossref","first-page":"102164","DOI":"10.1016\/j.tranon.2024.102164","article-title":"TRIM47 is a prognostic biomarker for gallbladder cancer and promotes tumor progression through regulating K63-linked ubiquitination of PARP1.","volume":"51","author":"Xu","year":"2024","journal-title":"Transl Oncol"},{"key":"R4-20250722","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"R5-20250722","doi-asserted-by":"crossref","first-page":"93","DOI":"10.5114\/ceh.2019.85166","article-title":"Epidemiology of gallbladder cancer.","volume":"5","author":"Rawla","year":"2019","journal-title":"Clin Exp Hepatol"},{"key":"R6-20250722","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1002\/cam4.1044","article-title":"Trend analysis and survival of primary gallbladder cancer in the United States: a 1973\u20132009 population-based study.","volume":"6","author":"Rahman","year":"2017","journal-title":"Cancer Med"},{"key":"R7-20250722","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1245\/s10434-016-5637-x","article-title":"A novel pathology-based preoperative risk score to predict locoregional residual and distant disease and survival for incidental gallbladder cancer: a 10-institution study from the U.S. extrahepatic biliary malignancy consortium.","volume":"24","author":"Ethun","year":"2017","journal-title":"Ann Surg Oncol"},{"key":"R8-20250722","doi-asserted-by":"crossref","first-page":"5006","DOI":"10.1002\/cam4.1772","article-title":"Pattern of distant metastases in primary extrahepatic bile-duct cancer: a SEER-based study.","volume":"7","author":"Wang","year":"2018","journal-title":"Cancer Med"},{"key":"R9-20250722","doi-asserted-by":"crossref","first-page":"1007374","DOI":"10.3389\/fonc.2022.1007374","article-title":"Development and validation of a nomogram to predict overall survival in patients with incidental gallbladder cancer: a retrospective cohort study.","volume":"12","author":"Xie","year":"2022","journal-title":"Front Oncol"},{"key":"R10-20250722","doi-asserted-by":"crossref","first-page":"1157057","DOI":"10.3389\/fonc.2023.1157057","article-title":"Development and validation of a prognostic nomogram for gallbladder papillary adenocarcinoma.","volume":"13","author":"Wang","year":"2023","journal-title":"Front Oncol"},{"key":"R11-20250722","doi-asserted-by":"crossref","first-page":"12297","DOI":"10.1007\/s00432-023-05116-z","article-title":"Effect of different surgical options on the long-term survival of stage I gallbladder cancer: a retrospective study based on SEER database and Chinese multi-institutional Registry.","volume":"149","author":"Ji","year":"2023","journal-title":"J Cancer Res Clin Oncol"},{"key":"R12-20250722","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.7150\/ijms.47073","article-title":"A novel nomogram predicting distant metastasis in T1 and T2 gallbladder cancer: a SEER-based study.","volume":"17","author":"Cai","year":"2020","journal-title":"Int J Med Sci"},{"key":"R13-20250722","doi-asserted-by":"crossref","first-page":"1012142","DOI":"10.3389\/fpubh.2022.1012142","article-title":"Associations between external beam radiotherapy and overall survival in patients with gallbladder cancer: a population-based study.","volume":"10","author":"Song","year":"2022","journal-title":"Front Public Health"},{"key":"R14-20250722","first-page":"115","article-title":"Cancer statistics in China, 2015.","volume":"66","author":"Chen","year":"2016","journal-title":"CA Cancer J Clin"},{"key":"R15-20250722","doi-asserted-by":"crossref","first-page":"e35551","DOI":"10.1016\/j.heliyon.2024.e35551","article-title":"A prognostic model and novel risk classification system for radical gallbladder cancer surgery: a population-based study and external validation.","volume":"10","author":"Feng","year":"2024","journal-title":"Heliyon"},{"key":"R16-20250722","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1001\/jama.2018.11815","article-title":"Gallbladder Cancer.","volume":"320","author":"Baiu","year":"2018","journal-title":"JAMA"},{"key":"R17-20250722","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1080\/00325481.2024.2345585","article-title":"Gallbladder cancer: surgical treatment, immunotherapy, and targeted therapy.","volume":"136","author":"Sun","year":"2024","journal-title":"Postgrad Med"},{"key":"R18-20250722","doi-asserted-by":"crossref","first-page":"473","DOI":"10.3892\/ol.2024.14606","article-title":"Evolving approaches in advanced gallbladder cancer with complete pathological response using chemo\u2011immunotherapy: a case report.","volume":"28","author":"Orlandi","year":"2024","journal-title":"Oncol Lett"},{"key":"R19-20250722","doi-asserted-by":"crossref","first-page":"977963","DOI":"10.3389\/fonc.2022.977963","article-title":"Successful conversion surgery for locally advanced gallbladder cancer after gemcitabine and nab-paclitaxel chemotherapy.","volume":"12","author":"Yang","year":"2022","journal-title":"Front Oncol"},{"key":"R20-20250722","doi-asserted-by":"crossref","first-page":"e173","DOI":"10.1016\/S1470-2045(14)71116-7","article-title":"Nomograms in oncology: more than meets the eye.","volume":"16","author":"Balachandran","year":"2015","journal-title":"Lancet Oncol"},{"key":"R21-20250722","doi-asserted-by":"crossref","first-page":"1486170","DOI":"10.3389\/fcell.2024.1486170","article-title":"Screening of pathologically significant diagnostic biomarkers in tears of thyroid eye disease based on bioinformatic analysis and machine learning.","volume":"12","author":"Shu","year":"2024","journal-title":"Front Cell Dev Biol"},{"key":"R22-20250722","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1016\/j.ejso.2022.01.023","article-title":"Clinicopathologic features, treatment, survival, and prognostic factors of combined hepatocellular and cholangiocarcinoma: a nomogram development based on SEER database and validation in multicenter study.","volume":"48","author":"Zhou","year":"2022","journal-title":"Eur J Surg Oncol"},{"key":"R23-20250722","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1186\/s12957-021-02445-6","article-title":"A nomogram model for predicting prognosis of obstructive colorectal cancer.","volume":"19","author":"Lv","year":"2021","journal-title":"World J Surg Oncol"},{"key":"R24-20250722","doi-asserted-by":"crossref","first-page":"1114847","DOI":"10.3389\/fonc.2023.1114847","article-title":"Construction and validation of a novel nomogram to predict cancer-specific survival in patients with gastric adenocarcinoma.","volume":"13","author":"Nie","year":"2023","journal-title":"Front Oncol"},{"key":"R25-20250722","doi-asserted-by":"crossref","first-page":"752176","DOI":"10.3389\/fendo.2021.752176","article-title":"Nomogram predicts risk and prognostic factors for bone metastasis of pancreatic cancer: a population-based analysis.","volume":"12","author":"Zhang","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R26-20250722","doi-asserted-by":"crossref","first-page":"5772","DOI":"10.1245\/s10434-022-11911-8","article-title":"Survival nomogram for young breast cancer patients based on the SEER database and an external validation cohort.","volume":"29","author":"Huang","year":"2022","journal-title":"Ann Surg Oncol"},{"key":"R27-20250722","doi-asserted-by":"crossref","first-page":"1427170","DOI":"10.3389\/fonc.2024.1427170","article-title":"Development and validation of a tumor marker-based model for the prediction of lung cancer: an analysis of a multicenter retrospective study in Shanghai, China.","volume":"14","author":"Hu","year":"2024","journal-title":"Front Oncol"},{"key":"R28-20250722","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1186\/s12957-024-03533-z","article-title":"Novel multifactor predictive model for postoperative survival in gallbladder cancer: a multi-center study.","volume":"22","author":"Deng","year":"2024","journal-title":"World J Surg Oncol"},{"key":"R29-20250722","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1007\/s10147-021-01891-2","article-title":"Development and external validation of a nomogram for predicting the effect of tumor size on cancer-specific survival of resected gallbladder cancer: a population-based study.","volume":"26","author":"Zhang","year":"2021","journal-title":"Int J Clin Oncol"},{"key":"R30-20250722","doi-asserted-by":"crossref","first-page":"6619149","DOI":"10.1155\/2021\/6619149","article-title":"A novel prognostic nomogram for gallbladder cancer after surgical resection: a single-center experience.","volume":"2021","author":"Ma","year":"2021","journal-title":"J Oncol"},{"key":"R31-20250722","doi-asserted-by":"crossref","first-page":"1183619","DOI":"10.3389\/fphar.2023.1183619","article-title":"Gallbladder cancer: current and future treatment options.","volume":"14","author":"Zhou","year":"2023","journal-title":"Front Pharmacol"},{"key":"R32-20250722","doi-asserted-by":"crossref","first-page":"3856","DOI":"10.12998\/wjcc.v10.i12.3856","article-title":"Successful multimodality treatment of metastatic gallbladder cancer: a case report and review of literature.","volume":"10","author":"Zhang","year":"2022","journal-title":"World J Clin Cases"},{"key":"R33-20250722","doi-asserted-by":"crossref","first-page":"6035","DOI":"10.1002\/cam4.4150","article-title":"Identification of the prognostic value of elevated ANGPTL4 expression in gallbladder cancer-associated fibroblasts.","volume":"10","author":"Wang","year":"2021","journal-title":"Cancer Med"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000043369","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T04:02:44Z","timestamp":1753156964000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000043369"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,18]]},"references-count":33,"journal-issue":{"issue":"29","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000043369","relation":{},"ISSN":["1536-5964"],"issn-type":[{"type":"electronic","value":"1536-5964"}],"subject":[],"published":{"date-parts":[[2025,7,18]]},"assertion":[{"value":"2025-03-15","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-06-27","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}